Breaking News Instant updates and real-time market news.

$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

12:17
09/08/20
09/08
12:17
09/08/20
12:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is bearish across the board. Advancing Issues: 1022 / Declining Issues: 2322 -- for a ratio of 0.4 to 1. Advancing Volume: 661,801,000 / Declining Volume: 1,143,606,000 -- for a ratio of 0.6 to 1. New 52-Week Highs: 36 / New 52-Week Lows: 43.

TODAY'S FREE FLY STORIES

Upgrade
NiSource upgraded to Buy ahead of investor day at Jefferies » 08:02
09/23/20
09/23
08:02
09/23/20
08:02
NI

NiSource

$22.08 /

-0.125 (-0.56%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NI NiSource
$22.08 /

-0.125 (-0.56%)

05:24 Today Jefferies
NiSource upgraded to Buy from Hold at Jefferies
04/30/20 BofA
NiSource downgraded to Neutral from Buy at BofA
04/24/20 Jefferies
NiSource downgraded to Hold following bounce back at Jefferies
04/24/20 Jefferies
NiSource downgraded to Hold from Buy at Jefferies
NI NiSource
$22.08 /

-0.125 (-0.56%)

Recommendations
Nike price target raised to $142 from $127 at Wedbush » 08:02
09/23/20
09/23
08:02
09/23/20
08:02
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Wedbush analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:42 Today Wells Fargo
Nike price target raised to $135 from $110 at Wells Fargo
07:33 Today Morgan Stanley
Nike price target raised to $152 from $142 at Morgan Stanley
07:32 Today Susquehanna
Nike price target raised to $160 from $150 at Susquehanna
07:22 Today Credit Suisse
Nike price target raised to $154 from $136 at Credit Suisse
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Hot Stocks
Tampa General Hospital announces strategic partnership with Philips » 08:02
09/23/20
09/23
08:02
09/23/20
08:02
PHG

Philips

$45.43 /

-0.47 (-1.02%)

pa General Hospital and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHG Philips
$45.43 /

-0.47 (-1.02%)

PHG Philips
$45.43 /

-0.47 (-1.02%)

09/01/20 UBS
Philips price target lowered to EUR 47 from EUR 48 at UBS
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
07/28/20 Societe Generale
Philips initiated with a Buy at Societe Generale
07/21/20 JPMorgan
Philips price target raised to EUR 39.50 from EUR 36.80 at JPMorgan
PHG Philips
$45.43 /

-0.47 (-1.02%)

PHG Philips
$45.43 /

-0.47 (-1.02%)

Recommendations
Brookfield shares remain undervalued, says JPMorgan » 08:02
09/23/20
09/23
08:02
09/23/20
08:02
BAM

Brookfield

$32.84 /

+0.3 (+0.92%)

JPMorgan analyst Kenneth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAM Brookfield
$32.84 /

+0.3 (+0.92%)

BAM Brookfield
$32.84 /

+0.3 (+0.92%)

08/17/20 Keefe Bruyette
Brookfield upgraded to Outperform from Market Perform at Keefe Bruyette
06/08/20 JPMorgan
Brookfield initiated with an Overweight at JPMorgan
04/08/20 TD Securities
Brookfield upgraded to Action List Buy from Buy at TD Securities
03/29/20 Keefe Bruyette
Brookfield downgraded to Market Perform from Outperform at Keefe Bruyette
BAM Brookfield
$32.84 /

+0.3 (+0.92%)

BAM Brookfield
$32.84 /

+0.3 (+0.92%)

BAM Brookfield
$32.84 /

+0.3 (+0.92%)

Options
Microsoft call buyer realizes 26% same-day gains » 08:00
09/23/20
09/23
08:00
09/23/20
08:00
MSFT

Microsoft

$207.42 /

+4.75 (+2.34%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

07:47 Today Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/22/20 Credit Suisse
Microsoft's ZeniMax deal fortifies subscription strategy, says Credit Suisse
09/22/20 Deutsche Bank
Deutsche Bank likes Microsoft acquisition of ZeniMax Media
MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

Recommendations
Aurora Cannabis price target lowered to C$9 from C$18 at MKM Partners » 07:59
09/23/20
09/23
07:59
09/23/20
07:59
ACB

Aurora Cannabis

$7.32 /

+0.99 (+15.64%)

MKM Partners analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

05:55 Today Piper Sandler
Aurora Cannabis price target lowered to $8 from $10 at Piper Sandler
09/22/20 Canaccord
Aurora Cannabis price target lowered to C$10 from C$21 at Canaccord
09/21/20 Jefferies
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
09/21/20 Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

ACB Aurora Cannabis
$7.32 /

+0.99 (+15.64%)

Recommendations
Massive cost reduction on Tesla's battery front on the horizon, says Wedbush » 07:59
09/23/20
09/23
07:59
09/23/20
07:59
TSLA

Tesla

$423.90 /

-25.41 (-5.66%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

07:50 Today Oppenheimer
Tesla should be bought on any near-term weakness, says Oppenheimer
07:28 Today Canaccord
Tesla price target lowered to $377 from $442 at Canaccord
07:26 Today Credit Suisse
Tesla Battery Day plan shows elevated growth narrative ahead, says Credit Suisse
07:24 Today Morgan Stanley
Morgan Stanley says Tesla battery technologies 'bearish for lithium'
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

  • 14
    Feb
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

Initiation
AssetMark Financial initiated with a Hold at Jefferies » 07:57
09/23/20
09/23
07:57
09/23/20
07:57
AMK

AssetMark Financial

$21.62 /

+0.12 (+0.56%)

Jefferies analyst Gerald…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMK AssetMark Financial
$21.62 /

+0.12 (+0.56%)

AMK AssetMark Financial
$21.62 /

+0.12 (+0.56%)

08/05/20 JPMorgan
AssetMark Financial downgraded on growth slowdown at JPMorgan
08/05/20 JPMorgan
AssetMark Financial downgraded to Neutral from Overweight at JPMorgan
07/15/20 Raymond James
AssetMark Financial price target raised to $31 from $27 at Raymond James
04/14/20 Raymond James
AssetMark Financial price target lowered to $26 from $29 at Raymond James
AMK AssetMark Financial
$21.62 /

+0.12 (+0.56%)

AMK AssetMark Financial
$21.62 /

+0.12 (+0.56%)

Periodicals
Amazon denies formal connection to 'Prime Bike,' The Verge reports » 07:57
09/23/20
09/23
07:57
09/23/20
07:57
AMZN

Amazon.com

$3,128.41 /

+167.41 (+5.65%)

, PTON

Peloton

$94.36 /

-0.395 (-0.42%)

Amazon (AMZN) has denied…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

PTON Peloton
$94.36 /

-0.395 (-0.42%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

07:47 Today Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
09/22/20
Fly Intel: Top five analyst upgrades
09/22/20 Loop Capital
Global Payments initiated with a Buy at Loop Capital
PTON Peloton
$94.36 /

-0.395 (-0.42%)

09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
09/22/20 Roth Capital
Peloton shares have path to $175, says Roth Capital
09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
09/16/20 Canaccord
Peloton on its way to connected fitness leadership, says Canaccord
AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

PTON Peloton
$94.36 /

-0.395 (-0.42%)

  • 26
    Sep
AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

PTON Peloton
$94.36 /

-0.395 (-0.42%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

PTON Peloton
$94.36 /

-0.395 (-0.42%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

PTON Peloton
$94.36 /

-0.395 (-0.42%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

Earnings
Centogene sees 2020 revenue EUR60M-EUR65M » 07:55
09/23/20
09/23
07:55
09/23/20
07:55
CNTG

Centogene

$11.08 /

+0.4699 (+4.43%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

04/24/20 BTIG
Centogene price target raised to $23 from $18 at BTIG
04/24/20 Evercore ISI
Centogene downgraded to In Line from Outperform at Evercore ISI
12/03/19 Baird
Centogene initiated with an Outperform at Baird
12/02/19 BTIG
Centogene initiated with a Buy at BTIG
CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

  • 10
    Jul
  • 07
    Nov
CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

General news
U.S. MBA reported mortgage applications surged 6.8% in the week ended September 18 » 07:55
09/23/20
09/23
07:55
09/23/20
07:55

U.S. MBA reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
TCF Financial removed from Best Ideas List at Wedbush » 07:54
09/23/20
09/23
07:54
09/23/20
07:54
TCF

TCF Financial

$22.99 /

-0.58 (-2.46%)

Wedbush removed TCF…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCF TCF Financial
$22.99 /

-0.58 (-2.46%)

TCF TCF Financial
$22.99 /

-0.58 (-2.46%)

06/08/20 BofA
TCF Financial upgraded to Buy from Neutral at BofA
06/08/20 BofA
TCF Financial upgraded to Buy from Neutral at BofA
04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
TCF TCF Financial
$22.99 /

-0.58 (-2.46%)

TCF TCF Financial
$22.99 /

-0.58 (-2.46%)

TCF TCF Financial
$22.99 /

-0.58 (-2.46%)

Earnings
Centogene reports Q2 (EUR0.52) vs. (EUR0.39) last year » 07:54
09/23/20
09/23
07:54
09/23/20
07:54
CNTG

Centogene

$11.08 /

+0.4699 (+4.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

04/24/20 BTIG
Centogene price target raised to $23 from $18 at BTIG
04/24/20 Evercore ISI
Centogene downgraded to In Line from Outperform at Evercore ISI
12/03/19 Baird
Centogene initiated with an Outperform at Baird
12/02/19 BTIG
Centogene initiated with a Buy at BTIG
  • 10
    Jul
  • 07
    Nov
CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

CNTG Centogene
$11.08 /

+0.4699 (+4.43%)

Recommendations
Marinus Pharmaceuticals price target raised to $28 from $7 at Oppenheimer » 07:53
09/23/20
09/23
07:53
09/23/20
07:53
MRNS

Marinus Pharmaceuticals

$12.56 /

-0.32 (-2.48%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNS Marinus Pharmaceuticals
$12.56 /

-0.32 (-2.48%)

MRNS Marinus Pharmaceuticals
$12.56 /

-0.32 (-2.48%)

09/15/20 SVB Leerink
First indication looking good for Marinus' Ganaxolone, says SVB Leerink
09/15/20 Oppenheimer
Marinus Pharmaceuticals price target raised to $7 from $6 at Oppenheimer
09/15/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $8 from $6 at Cantor Fitzgerald
09/15/20 Jefferies
Marinus Pharmaceuticals price target raised to $6 from $4 at Jefferies
MRNS Marinus Pharmaceuticals
$12.56 /

-0.32 (-2.48%)

  • 29
    May
  • 11
    Dec
MRNS Marinus Pharmaceuticals
$12.56 /

-0.32 (-2.48%)

MRNS Marinus Pharmaceuticals
$12.56 /

-0.32 (-2.48%)

Recommendations
Pentair price target raised to $52 from $47 at Oppenheimer » 07:52
09/23/20
09/23
07:52
09/23/20
07:52
PNR

Pentair

$45.38 /

+0.78 (+1.75%)

Oppenheimer analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNR Pentair
$45.38 /

+0.78 (+1.75%)

PNR Pentair
$45.38 /

+0.78 (+1.75%)

09/16/20 JPMorgan
Pentair price target raised to $55 from $52 at JPMorgan
09/14/20 Citi
Pentair upgraded to Buy from Neutral at Citi
07/24/20 RBC Capital
Pentair price target raised to $44 from $39 at RBC Capital
07/09/20 BofA
Pentair double-upgraded to Buy from Underperform at BofA
PNR Pentair
$45.38 /

+0.78 (+1.75%)

PNR Pentair
$45.38 /

+0.78 (+1.75%)

Recommendations
Tesla should be bought on any near-term weakness, says Oppenheimer » 07:50
09/23/20
09/23
07:50
09/23/20
07:50
TSLA

Tesla

$423.90 /

-25.41 (-5.66%)

Oppenheimer analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

07:28 Today Canaccord
Tesla price target lowered to $377 from $442 at Canaccord
07:26 Today Credit Suisse
Tesla Battery Day plan shows elevated growth narrative ahead, says Credit Suisse
07:24 Today Morgan Stanley
Morgan Stanley says Tesla battery technologies 'bearish for lithium'
07:22 Today Baird
Tesla designated a bearish Fresh Pick at Baird
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

  • 14
    Feb
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

Recommendations
Western Digital reorganization could be precursor to spinoff, says Benchmark » 07:49
09/23/20
09/23
07:49
09/23/20
07:49
WDC

Western Digital

$36.46 /

+0.36 (+1.00%)

After Western Digital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$36.46 /

+0.36 (+1.00%)

WDC Western Digital
$36.46 /

+0.36 (+1.00%)

07:18 Today Craig-Hallum
Western Digital upgraded to Buy from Hold at Craig-Hallum
09/22/20 Susquehanna
Susquehanna updates estimates for Western Digital and Seagate
09/20/20 Deutsche Bank
Western Digital named short-term buy idea at Deutsche Bank
08/12/20 Deutsche Bank
Micron downgraded to Hold from Buy at Deutsche Bank
WDC Western Digital
$36.46 /

+0.36 (+1.00%)

WDC Western Digital
$36.46 /

+0.36 (+1.00%)

WDC Western Digital
$36.46 /

+0.36 (+1.00%)

WDC Western Digital
$36.46 /

+0.36 (+1.00%)

Recommendations
Benchmark says Microsoft partnership can be 'big driver' for Kratos » 07:47
09/23/20
09/23
07:47
09/23/20
07:47
KTOS

Kratos Defense

$18.88 /

-0.865 (-4.38%)

, MSFT

Microsoft

$207.42 /

+4.75 (+2.34%)

, AMZN

Amazon.com

$3,128.41 /

+167.41 (+5.65%)

Benchmark analyst Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

09/22/20
Fly Intel: Top five analyst downgrades
09/22/20 JPMorgan
Kratos Defense downgraded to Neutral on valuation at JPMorgan
09/22/20 JPMorgan
Kratos Defense downgraded to Neutral from Overweight at JPMorgan
08/03/20 Canaccord
Kratos Defense second half catalysts should support shares. says Canaccord
MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

09/22/20 Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
09/22/20 Credit Suisse
Microsoft's ZeniMax deal fortifies subscription strategy, says Credit Suisse
09/22/20 Deutsche Bank
Deutsche Bank likes Microsoft acquisition of ZeniMax Media
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
09/22/20
Fly Intel: Top five analyst upgrades
09/22/20 Loop Capital
Global Payments initiated with a Buy at Loop Capital
09/22/20 Bernstein
Bernstein upgrades Amazon.com to Outperform after 16% pullback
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

  • 19
    Jun
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

AMZN Amazon.com
$3,128.41 /

+167.41 (+5.65%)

Recommendations
Blueprint Medicines price target raised to $113 from $105 at BMO Capital » 07:45
09/23/20
09/23
07:45
09/23/20
07:45
BPMC

Blueprint Medicines

$87.34 /

+10.1 (+13.08%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$87.34 /

+10.1 (+13.08%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$87.34 /

+10.1 (+13.08%)

06:27 Today Barclays
Blueprint Medicines price target raised to $90 from $77 at Barclays
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

05:12 Today Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
BPMC Blueprint Medicines
$87.34 /

+10.1 (+13.08%)

RHHBY Roche
$0.00 /

+ (+0.00%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$87.34 /

+10.1 (+13.08%)

RHHBY Roche
$0.00 /

+ (+0.00%)

General news
Treasury Market Outlook: equities are extending gains » 07:45
09/23/20
09/23
07:45
09/23/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
KB Home price target raised to $49 from $43 at Wells Fargo » 07:44
09/23/20
09/23
07:44
09/23/20
07:44
KBH

KB Home

$40.51 /

+1.61 (+4.14%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

07:22 Today RBC Capital
KB Home price target raised to $42 from $36 at RBC Capital
06:27 Today Barclays
KB Home price target raised to $45 from $42 at Barclays
04:50 Today KeyBanc
KB Home downgraded to Sector Weight from Overweight at KeyBanc
09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

Recommendations
Nike price target raised to $135 from $110 at Wells Fargo » 07:42
09/23/20
09/23
07:42
09/23/20
07:42
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Wells Fargo analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:33 Today Morgan Stanley
Nike price target raised to $152 from $142 at Morgan Stanley
07:32 Today Susquehanna
Nike price target raised to $160 from $150 at Susquehanna
07:22 Today Credit Suisse
Nike price target raised to $154 from $136 at Credit Suisse
07:18 Today Raymond James
Nike price target raised to $140 from $121 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Initiation
Open Lending initiated with a Buy at DA Davidson » 07:41
09/23/20
09/23
07:41
09/23/20
07:41
LPRO

Open Lending

$22.20 /

+1.28 (+6.12%)

DA Davidson analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPRO Open Lending
$22.20 /

+1.28 (+6.12%)

LPRO Open Lending
$22.20 /

+1.28 (+6.12%)

09/21/20 Canaccord
Open Lending data provides attractive setup exiting Q3, says Canaccord
08/12/20 Canaccord
Open Lending price target raised to $25 from $20 at Canaccord
07/24/20
Fly Intel: Top five analyst initiations
07/24/20 Deutsche Bank
Deutsche Bank starts Open Lending with Buy, $23 price target
LPRO Open Lending
$22.20 /

+1.28 (+6.12%)

LPRO Open Lending
$22.20 /

+1.28 (+6.12%)

Recommendations
HubSpot price target raised to $270 from $245 at Wells Fargo » 07:40
09/23/20
09/23
07:40
09/23/20
07:40
HUBS

HubSpot

$281.85 /

-3.16 (-1.11%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUBS HubSpot
$281.85 /

-3.16 (-1.11%)

07:29 Today Stifel
HubSpot price target raised to $305 after analyst day at Stifel
07:26 Today Canaccord
HubSpot price target raised to $325 from $285 at Canaccord
07:25 Today RBC Capital
HubSpot price target raised to $328 from $280 at RBC Capital
07:17 Today Raymond James
HubSpot price target raised to $320 from $265 at Raymond James
HUBS HubSpot
$281.85 /

-3.16 (-1.11%)

HUBS HubSpot
$281.85 /

-3.16 (-1.11%)

Hot Stocks
DraftKings appoints Jocelyn Moore, Valerie Mosley to board of directors » 07:39
09/23/20
09/23
07:39
09/23/20
07:39
DKNG

DraftKings

$53.92 /

+2.44 (+4.74%)

DraftKings announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/15/20 Craig-Hallum
DraftKings price target raised to $60 from $48 at Craig-Hallum
09/15/20 Benchmark
DraftKings price target raised to $57 from $45 at Benchmark
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

  • 19
    Jun
DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

DKNG DraftKings
$53.92 /

+2.44 (+4.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.